Stockreport

Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF -- Kite and Teneobio will Collaborate on Next-Generation Dual-Targeting CAR T Therapies in Multiple Myeloma Utilizing UniAb® Antibodies -- SANTA MONICA, Calif. & NEWA [Read more]